Matrivax Research & Development Corporation
Matrivax Research & Development Corporation, based in Boston, MA, is at the forefront of vaccine innovation, dedicated to developing life-saving vaccines for populations in need worldwide. Their efforts focus on a next-generation pneumococcal vaccine and a novel C. difficile vaccine, both addressing critical global health threats.
The pneumococcal vaccine aims to significantly reduce the impact of Streptococcus pneumoniae infections, which claim over one million lives annually. Meanwhile, the C. difficile vaccine targets the bacteria and toxins responsible for a substantial number of infections in the U.S., presenting a promising solution to an urgent public health crisis.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
